Industry Events
EnglishFrançaisEspañol中文العربية
الفعالياتالأخبارالرؤىالمنظمون
الخدمات
  • تسويق الفعالياتانشر وروّج وطوّر فعالياتك أمام جمهور B2B عالمي.
  • البيان الصحفيوزّع إعلاناتك الرسمية على المتخصصين في الصناعة حول العالم.
  • ترويج المتحدثين والخبراءاعرض خبرتك واحصل على دعوات للمحاضرات والجلسات النقاشية.
اشتراك
تسجيل دخول المتحدثينأضف فعاليتك مجاناً
Industry Events

المنصة العالمية الأكثر موثوقية لاكتشاف فعاليات B2B. نربط المهنيين في الصناعة بالمؤتمرات والمعارض والقمم المهمة.

  • فعاليات الصناعة
  • الأخبار
  • منظمو الفعاليات
  • من نحن
  • خدماتنا
  • منظم مميز
  • Event Pro
  • كن متحدثاً
  • اشتراك
  • الشروط
  • الخصوصية

© 2026 Industry Events Worldwide. جميع الحقوق محفوظة.

VF96.7.
  • الفعاليات
  • الأخبار
  • الرؤى
  • الحساب
Industry Events
EnglishFrançaisEspañol中文العربية
الفعالياتالأخبارالرؤىالمنظمون
الخدمات
  • تسويق الفعالياتانشر وروّج وطوّر فعالياتك أمام جمهور B2B عالمي.
  • البيان الصحفيوزّع إعلاناتك الرسمية على المتخصصين في الصناعة حول العالم.
  • ترويج المتحدثين والخبراءاعرض خبرتك واحصل على دعوات للمحاضرات والجلسات النقاشية.
اشتراك
تسجيل دخول المتحدثينأضف فعاليتك مجاناً
Industry Events

News

Categories

  • الأحدث
  • أشباه الموصلات
  • الأمن السيبراني
  • التكنولوجيا المالية
  • الدفاع
  • الذكاء الاصطناعي والتقنية
  • الرعاية الصحية
  • الروبوتات
  • الزراعة
  • الشركات الناشئة ورأس المال المخاطر
  • الصين ومجموعة بريكس+
  • الطاقة والتنقل
  • سلسلة الإمداد

Select a category to explore the latest industry reporting.

NewsTuesday, 25 August 2026
Newsletter subscribe · Free
  • الأحدث
  • الذكاء الاصطناعي والتقنية
  • الأمن السيبراني
  • أشباه الموصلات
  • الروبوتات
  • التكنولوجيا المالية
  • الطاقة والتنقل
  • الدفاع
  • الرعاية الصحية
  • سلسلة الإمداد
  • الشركات الناشئة ورأس المال المخاطر
  • الصين ومجموعة بريكس+
  • الزراعة

الأخبار

الرعاية الصحية

أحدث أخبار الرعاية الصحية والإعلانات والتحليلات من المؤتمرات والمعارض والقمم التي تشكّل القطاع.

الأحدث في القسم

STAT+: FDA approves Replimune melanoma drug previously rejected twice (opens original source in a new tab)
STAT News

STAT+: FDA approves Replimune melanoma drug previously rejected twice

Industry Events

المنصة العالمية الأكثر موثوقية لاكتشاف فعاليات B2B. نربط المهنيين في الصناعة بالمؤتمرات والمعارض والقمم المهمة.

The FDA approved Replimune’s treatment for advanced melanoma, dealing the company and patient advocates a big win after a tumultuous saga.

(opens original source in a new tab)
Elaine Chen·6 August 2026
STAT+: Medicare quietly gave blockbuster AbbVie drug seven extra years before price negotiations, advocacy group asserts (opens original source in a new tab)
STAT News

STAT+: Medicare quietly gave blockbuster AbbVie drug seven extra years before price negotiations, advocacy group asserts

A little-noticed government policy shift caused a seven-year delay in choosing a costly medicine for Medicare price negotiations, an advocacy group says.

(opens original source in a new tab)
Ed Silverman·6 August 2026
STAT+: Study reveals new role for tau, a top target for Alzheimer’s drug development (opens original source in a new tab)
STAT News

STAT+: Study reveals new role for tau, a top target for Alzheimer’s drug development

The protein tau is top target for Alzheimer’s drug development, and a new study bolsters those efforts by describing a previously unknown role that tau plays in neurodegeneration.

(opens original source in a new tab)
Jonathan Wosen·6 August 2026
STAT+: Two FDA approvals — a new drug and a new vaccine (opens original source in a new tab)
STAT News

STAT+: Two FDA approvals — a new drug and a new vaccine

Takeda's narcolepsy drug approved, the first mRNA flu shot approved, and more biotech updates from The Readout

(opens original source in a new tab)
STAT Staff·6 August 2026
U.S. moves to shut a Kentucky organ donation group, citing safety failures (opens original source in a new tab)
STAT News

U.S. moves to shut a Kentucky organ donation group, citing safety failures

The U.S. moves to shut a Kentucky organ donation group that's been accused of continuing plans for organ retrieval from some patients who unexpectedly showed signs of life.

(opens original source in a new tab)
Associated Press·6 August 2026
Opinion: The U.S. needs a 9/11 Commission-style independent body to investigate Covid response (opens original source in a new tab)
STAT News

Opinion: The U.S. needs a 9/11 Commission-style independent body to investigate Covid response

“A transparent evaluation of Covid would separate what happened from competing political narratives and help us improve for the future,” writes IDSA President Ronald Nahass.

(opens original source in a new tab)
Ronald Nahass·6 August 2026
Senate committee votes along party lines to hold Fauci in contempt of Congress (opens original source in a new tab)
STAT News

Senate committee votes along party lines to hold Fauci in contempt of Congress

A Senate committee has voted to hold Anthony Fauci in contempt of Congress after he declined to answer questions about his role in the Covid pandemic.

(opens original source in a new tab)
Daniel Payne·6 August 2026
FDA approves Moderna’s mRNA flu vaccine, the first to use the technology (opens original source in a new tab)
STAT News

FDA approves Moderna’s mRNA flu vaccine, the first to use the technology

The FDA has approved Moderna’s influenza vaccine, the first licensed flu shot made using messenger RNA technology.

(opens original source in a new tab)
Helen Branswell·6 August 2026
Welp, Nobody Saw SpaceX’s Falcon 9 Rocket Crash Into the Moon (opens original source in a new tab)
Wired

Welp, Nobody Saw SpaceX’s Falcon 9 Rocket Crash Into the Moon

Although no one captured a direct image of the impact, scientists have detected signals confirming the rocket hit the lunar surface. Orbiters could provide the first images of the crash site in the coming days.

(opens original source in a new tab)
Jorge Garay·5 August 2026
STAT+: Takeda’s narcolepsy drug approved by the FDA, seen as a boon for new class of treatments (opens original source in a new tab)
STAT News

STAT+: Takeda’s narcolepsy drug approved by the FDA, seen as a boon for new class of treatments

The FDA approved a novel type of treatment for narcolepsy made by Takeda, backing a new drug class that scientists hope can be used to treat other conditions.

(opens original source in a new tab)
Elaine Chen·5 August 2026
STAT+: Federal regulators invite industry, researchers, and lobbyists to closed-door meetings on clinical AI (opens original source in a new tab)
STAT News

STAT+: Federal regulators invite industry, researchers, and lobbyists to closed-door meetings on clinical AI

Federal health officials invited tech companies and lobbyists to closed-door meetings as they seek to boost adoption of clinical AI.

(opens original source in a new tab)
Mario Aguilar·5 August 2026
Erica Schwartz confirmed as CDC director, filling nearly yearlong vacancy (opens original source in a new tab)
STAT News

Erica Schwartz confirmed as CDC director, filling nearly yearlong vacancy

Now confirmed, Erica Schwartz is the third CDC nominee since Trump took office for his second term.

(opens original source in a new tab)
Chelsea Cirruzzo·5 August 2026

الأكثر قراءة

  1. 01

    STAT+: FDA approves Replimune melanoma drug previously rejected twice

  2. 02

    STAT+: Medicare quietly gave blockbuster AbbVie drug seven extra years before price negotiations, advocacy group asserts

  3. 03

    STAT+: Study reveals new role for tau, a top target for Alzheimer’s drug development

  4. 04

    STAT+: Two FDA approvals — a new drug and a new vaccine

  5. 05

    U.S. moves to shut a Kentucky organ donation group, citing safety failures

Prev
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
Next
  • فعاليات الصناعة
  • الأخبار
  • منظمو الفعاليات
  • من نحن
  • خدماتنا
  • منظم مميز
  • Event Pro
  • كن متحدثاً
  • اشتراك
  • الشروط
  • الخصوصية

© 2026 Industry Events Worldwide. جميع الحقوق محفوظة.

VF96.7.

أسبوع فعاليات الصناعة، يُوصَّل كل جمعة.

بريد إلكتروني قصير واحد. أبرز القصص من المعارض التجارية والمؤتمرات والقمم التي تشكّل الأعمال حول العالم. بلا حشو، بلا بريد عشوائي، إلغاء الاشتراك في أي وقت.